Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Louis Brogley is active.

Publication


Featured researches published by Louis Brogley.


Bioorganic & Medicinal Chemistry Letters | 2010

Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.

Roy K. Hom; Simeon Bowers; Jennifer Sealy; Anh P. Truong; Gary D. Probst; Martin L. Neitzel; R. Jeffrey Neitz; Larry Fang; Louis Brogley; Jing Wu; Andrei W. Konradi; Hing L. Sham; Gergely Toth; Hu Pan; Nanhua Yao; Dean R. Artis; Kevin P. Quinn; John-Michael Sauer; Kyle Powell; Zhao Ren; Frederique Bard; Ted Yednock; Irene Griswold-Prenner

From high throughput screening, we discovered compound 1, the prototype for a series of disubstituted thiophene inhibitors of JNK which is selective towards closely related MAP kinases p38 and Erk2. Herein we describe the evolution of these compounds to a novel class of thiophene and thiazole JNK inhibitors that retain favorable solubility, permeability, and P-gp properties for development as CNS agents for treatment of neurodegeneration. Compound 61 demonstrated JNK3 IC(50)=77 nM and retained the excellent broad kinase selectivity observed for the series.


Journal of Medicinal Chemistry | 2007

Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human β-Secretase†

Michel Maillard; Roy K. Hom; Timothy E. Benson; Joseph B. Moon; Shumeye S. Mamo; Michael J. Bienkowski; Alfredo G. Tomasselli; D. Danielle Woods; D. Bryan Prince; Donna J. Paddock; Thomas L. Emmons; John A. Tucker; Michael S. Dappen; Louis Brogley; Eugene D. Thorsett; Nancy Jewett; and Sukanto Sinha; Varghese John


Bioorganic & Medicinal Chemistry Letters | 2009

Design and synthesis of cell potent BACE-1 inhibitors: Structure–activity relationship of P1′ substituents

Jennifer Sealy; Anh P. Truong; L Tso; Gary D. Probst; Jose Aquino; Roy K. Hom; Barbara Jagodzinska; Darren B. Dressen; David W. G. Wone; Louis Brogley; John; Jay S. Tung; Michael A. Pleiss; John A. Tucker; Andrei W. Konradi; Michael S. Dappen; Gergley Tóth; Hu Pan; Lany Ruslim; J Miller; Michael P. Bova; Sukanto Sinha; Kevin P. Quinn; John-Michael Sauer


Bioorganic & Medicinal Chemistry Letters | 2010

Improving the permeability of the hydroxyethylamine BACE-1 inhibitors: structure-activity relationship of P2' substituents.

Anh P. Truong; Gary D. Probst; Jose Aquino; Larry Fang; Louis Brogley; Jennifer Sealy; Roy K. Hom; John A. Tucker; Varghese John; Jay S. Tung; Michael A. Pleiss; Andrei W. Konradi; Hing L. Sham; Michael S. Dappen; Gergley Tóth; Nanhua Yao; Eric Brecht; Hu Pan; Dean R. Artis; Lany Ruslim; Michael P. Bova; Sukanto Sinha; Ted Yednock; Wes Zmolek; Kevin P. Quinn; John-Michael Sauer


Archive | 2005

Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors

Varghese John; Michel Maillard; Lawrence Fang; John A. Tucker; Louis Brogley; Jose Aquino; Simeon Bowers; Gary D. Probst; Jay S. Tung


Archive | 2005

Substituted hydroxyethylamine aspartyl protease inhibitors

Varghese John; Michel Maillard; John A. Tucker; Jose Aquino; Barbara Jagodzinska; Louis Brogley; Jay S. Tung; Simeon Bowers; Darren B. Dressen; Gary D. Probst; Neerav Shah


Archive | 2003

Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists

Francine S. Grant; Sarah Bartulis; Louis Brogley; Michael S. Dappen; Ramesh Kasar; Mohammed A. Khan; Martin L. Neitzel; Michael A. Pleiss; Eugene D. Thorsett; John A. Tucker; Michael Ye; Jon E. Hawkinson


Archive | 2003

Hydroxypropyl amides for the treatment of Alzheimer's disease

John A. Tucker; Brian A. Sherer; Ying Zi Xu; Louis Brogley; Shon R. Pulley; Jon S. Jacobs; James P. Beck; Varghese John


Bioorganic & Medicinal Chemistry Letters | 2013

Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.

Raymond Ng; Minghua Sun; Simeon Bowers; Roy K. Hom; Gary D. Probst; Varghese John; Lawrence Y. Fang; Michel Maillard; Andrea Gailunas; Louis Brogley; R. Jeffrey Neitz; Jay S. Tung; Michael A. Pleiss; Andrei W. Konradi; Hing L. Sham; Michael S. Dappen; Marc Adler; Nanhua Yao; Wes Zmolek; David Nakamura; Kevin P. Quinn; John-Michael Sauer; Michael P. Bova; Lany Ruslim; Dean R. Artis; Ted Yednock


Archive | 2003

Sulfonylquinoxalone derivatives as bradykinin antagonists

Francine S. Grant; Sarah Bartulis; Louis Brogley; Michael S. Dappen; Ramesh Kasar; Ryan Holcomb; Michael A. Pleiss; Eugene D. Thorsett; Michael Ye; Jon E. Hawkinson

Collaboration


Dive into the Louis Brogley's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gary D. Probst

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Michel Maillard

Institut de Chimie des Substances Naturelles

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barbara Jagodzinska

Buck Institute for Research on Aging

View shared research outputs
Researchain Logo
Decentralizing Knowledge